Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2010
07/07/2010CN101766747A Miao nationality linimentum for treating haemorrhoid and preparation method thereof
07/07/2010CN101766727A Traditional Chinese medicine combination for high blood pressure and preparation method thereof
07/07/2010CN101766726A Medicine combination for treating high blood pressure and preparation method thereof
07/07/2010CN101766706A Medicinal combination containing borneol and musk
07/07/2010CN101766705A Medicinal combination containing borneol and musk
07/07/2010CN101766704A Medicinal combination containing borneol and musk
07/07/2010CN101766703A Medicinal combination containing borneol and musk
07/07/2010CN101766702A Medicinal combination containing borneol and musk
07/07/2010CN101766701A Medicinal combination containing musk
07/07/2010CN101766700A Medicinal combination containing musk
07/07/2010CN101766699A Medicinal combination containing musk
07/07/2010CN101766694A Process for extracting total glucosides from desertliving cistanche and preparation thereof
07/07/2010CN101766690A Multipurpose utilization method for improving the value of schisandra chinensis medicinal material
07/07/2010CN101766686A Pharmaceutical composite for treating cerebral stroke, preparation method and application thereof
07/07/2010CN101766685A Pharmaceutical composite for treating cerebral stroke, preparation method and application thereof
07/07/2010CN101766684A Chinese medicine composite for treating cardiovascular diseases and preparation method thereof
07/07/2010CN101766683A Salvia dispersible tablet and application thereof
07/07/2010CN101766682A Process for extracting and purifying total alkaloids of Sophora alopecuroides
07/07/2010CN101766675A Preparation method of silktree albizia bark extract for inhibiting angiogenesis and application
07/07/2010CN101766674A Medicament composition for preventing and controlling restenosis after intracoronary stent implantation
07/07/2010CN101766671A Pharmaceutical composition for preventing and treating restenosis after coronary stent implantation and preparation method thereof
07/07/2010CN101766670A Rhodiola rosea polyphenol microcapsule and preparation method
07/07/2010CN101766666A Chinese medicament for treating cardiovascular and cerebrovascular diseases
07/07/2010CN101766651A Purpose of corbicula water extract
07/07/2010CN101766631A Prostaglandin composition for injection
07/07/2010CN101766630A Lisinopril compound preparation and preparation method thereof
07/07/2010CN101766629A Propranolol compound preparation and preparation method thereof
07/07/2010CN101766618A New use of pitavastatin calcium and drug aiming at new use
07/07/2010CN101766611A Medical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta-blocker and application thereof
07/07/2010CN101766610A Amlodipine and eprosartan mesylate compound preparation
07/07/2010CN101766609A Amlodipine besylate compound preparation and preparation method thereof
07/07/2010CN101766607A Enalapril compound preparation and preparation method thereof
07/07/2010CN101766600A Compound candesartan cilexetil preparation and prepration method thereof
07/07/2010CN101766598A Drug combination containing perindopril
07/07/2010CN101766590A Combination for protecting peroxide injury of myocardium
07/07/2010CN101766585A Medical paste film
07/07/2010CN101766582A Levamlodipine beaylate tablets and preparation method thereof
07/07/2010CN101766581A Diltiazem hydrochloride timing controlled release tablet in group-hole released way and preparation method thereof
07/07/2010CN101766574A Preparation formulations of sodium pyruvate freeze-dried powder injection, injection and solid agent and production processes thereof
07/07/2010CN101766568A Emulsion containing clevidipine and preparation process and application thereof
07/07/2010CN101766566A Method for preparing injection of sodium ferulate
07/07/2010CN101307020B Amlodipine-zinc sulfate salts, preparing process thereof and application thereof
07/07/2010CN101229156B Medicine composition used for cardiovascular disorders
07/07/2010CN101229141B Aspirin sustained release tablet and preparing method thereof
07/07/2010CN101032532B Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof
07/07/2010CN101015545B Use of phenylpropionic acid and phenyl propyl compound with oxidation resistance function for protecting liver and brain damage
07/07/2010CN101015544B Use of phenyl propyl compound with oxidation resistance function for protecting liver and brain damage
07/07/2010CN101015543B Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage
07/07/2010CN101002930B Medicine composition containing aniracetam and brain protein hydrolyte
07/06/2010US7750161 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists
07/06/2010US7750150 Process for producing acid adduct salt of polyacidic base compound
07/06/2010US7750053 Compositions and methods for alleviating hypertension or preventing a rise in blood pressure
07/06/2010US7750041 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents
07/06/2010US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof
07/06/2010US7749998 urotensin antagonists such as N-[1-(4-biphenyl)-1)-2-(1-pyrrolidinyl)ethyl]-2-(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-N-methylacetamide, used for treating congestive heart failure, stroke, ischemia, angina, overactive bladder or arrhythmia
07/06/2010US7749993 Utillizing vasopressin antagonistic agent such as 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine; safe with few side effects
07/06/2010US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
07/06/2010US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
07/06/2010US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies
07/06/2010US7749725 Monitoring sensitivity of humans to sodium; obtain fluid sample, measure concentration og angiotensin enzyme in sample, evaluate for sensitivity to sodium
07/06/2010US7748379 Methods and apparatus for relieving headaches, rhinitis and other common ailments
07/06/2010CA2522761C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
07/06/2010CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/06/2010CA2446149C Vitamin d analogues
07/06/2010CA2427429C Acylaminoalkyl-substituted benzenesulfonamide derivatives,their preparation, their use and pharmaceutical preparations comprising them
07/06/2010CA2415962C Valsartan salts
07/06/2010CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
07/06/2010CA2359462C Pyrazole compounds and uses thereof
07/06/2010CA2333188C Multiparticulate pharmaceutical form with programmed and timed release and preparation method
07/01/2010WO2010075347A2 Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
07/01/2010WO2010075271A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010WO2010075263A2 Compounds and methods for enhancing erythropoiesis
07/01/2010WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
07/01/2010WO2010074807A1 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010074220A1 Composition containing sesamins and epigallocatechin gallate
07/01/2010WO2010074218A1 Anti-human midkine antibody
07/01/2010WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
07/01/2010WO2010073544A1 Method for testing risk of coronary artery diseases
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010073011A2 Compounds useful as medicaments
07/01/2010WO2010072950A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
07/01/2010WO2010072930A1 Novel method for the synthesis of ivabradine
07/01/2010WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity
07/01/2010WO2010072166A1 Preparation method of dihydroindene amide compounds,their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
07/01/2010WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands
07/01/2010WO2010037050A3 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
07/01/2010WO2010030983A3 Pyrazole carboxamide inhibitors of factor xa
07/01/2010WO2010030395A3 Withaferin a analogs and uses thereof
07/01/2010WO2010028190A3 Compounds, compositions and methods of using same for modulating uric acid levels
07/01/2010WO2010025459A3 Novel anti-arrhythmia agent
07/01/2010WO2010000851A3 Methods for modulating angiogenesis via dystrophin dp71
07/01/2010US20100169985 Transgenic Mouse Models for Diseases Caused by mtDNA Mutations and Related Methods
07/01/2010US20100168245 Preparation of (r,r)-fenoterol and (r,r)-or (r,s)-fenoterol analogues and their use in treating congestive heart failure
07/01/2010US20100168244 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
07/01/2010US20100168243 Renin Inhibitors
07/01/2010US20100168240 Substituted dibenzoic acid derivatives and use thereof
07/01/2010US20100168216 Prostaglandin pharmaceutical compositions
07/01/2010US20100168204 Therapeutic uses of inhibitors of RTP801L
07/01/2010US20100168201 Polymorphs of [R-(R*, R*) ]-2-(4-Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Magnesium Salt (2:1)
1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 1595